During the past decade, Università degli Studi - Policlinico di Tor Vergata conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 2 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Università degli Studi - Policlinico di Tor Vergata" #1 collaborator was "Study Alliance Leukemia (SAL) Group" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Università degli Studi - Policlinico di Tor Vergata" are "Acute Lymphoblastic Leukemia" (4 trials), "Chronic Myeloid Leukemia" (3 trials), "Leukemia" (3 trials), "Multiple Myeloma" (2 trials) and "Myelodysplastic Syndrome" (2 trials). Many other conditions were trialed in "Università degli Studi - Policlinico di Tor Vergata" in a lesser frequency.

Most popular intervention types in "Università degli Studi - Policlinico di Tor Vergata" are "Drug" (15 trials), "Other" (4 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Nilotinib" (2 trials), "all-trans retinoic acid (ATRA)" (2 trials), "mercaptopurine" (2 trials), "methotrexate" (2 trials) and "Antibiotic and antifungal drugs" (1 trials). Other intervention names were less common.

The vast majority of trials in "Università degli Studi - Policlinico di Tor Vergata" are 21 trials for "All" genders.

Currently, there are NaN active trials in "Università degli Studi - Policlinico di Tor Vergata". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Università degli Studi - Policlinico di Tor Vergata, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Università degli Studi - Policlinico di Tor Vergata, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".

Università degli Studi - Policlinico di Tor Vergata has several departments that took part in Clinical trials: "Department of Experimental Medicine" - 3 trials, "Cattedra E Divisione Di Ematologia, Università Tor Vergata, Ospedale S.Eugenio" - 2 trials